Profiel
Kolby Day is currently the Chief Operating Officer at Biomebank since 2023.
Prior to this, he worked as a Principal at Myriad Genetics, Inc. and as the VP, General Manager-Research & Development at Arteriocyte Medical Systems, Inc. Mr. Day has a graduate degree from Case Western Reserve University and an undergraduate degree from Southern Utah University.
Actieve functies van Kolby Day
| Bedrijven | Functie | Begin |
|---|---|---|
Biomebank
 Biomebank BiotechnologyHealth Technology Biomebank is an Australian clinical stage biotechnology company that aims to prevent diseases by restoring gut microbial ecology through microbiome-based therapies. The company is based in Thebarton, Australia. Biomebank's product is the world's first approved microbiome-based therapy for the treatment of recurrent and refractory clostridioides difficile infection. The company was founded by Rob Bryant and Sam Costello, with Sam Costello serving as the CEO since incorporation. | Operationeel Directeur | 29-08-2023 |
Eerdere bekende functies van Kolby Day
| Bedrijven | Functie | Einde |
|---|---|---|
| MYRIAD GENETICS, INC. | Corporate Officer/Principal | - |
Arteriocyte Medical Systems, Inc.
 Arteriocyte Medical Systems, Inc. Medical SpecialtiesHealth Technology Arteriocyte Medical Systems, Inc. develops and markets novel medical products. The firms products include Magellan, Magellan PRP, mar0max, mar0match and mar0fuse. It divisions include compass biomedical and discover truPRP. The company was founded in 2007 and is headquartered in Hopkinton, MA. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Kolby Day
| Southern Utah University | Undergraduate Degree |
| Case Western Reserve University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| MYRIAD GENETICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Arteriocyte Medical Systems, Inc.
Arteriocyte Medical Systems, Inc. Medical SpecialtiesHealth Technology Arteriocyte Medical Systems, Inc. develops and markets novel medical products. The firms products include Magellan, Magellan PRP, mar0max, mar0match and mar0fuse. It divisions include compass biomedical and discover truPRP. The company was founded in 2007 and is headquartered in Hopkinton, MA. | Health Technology |
Biomebank
Biomebank BiotechnologyHealth Technology Biomebank is an Australian clinical stage biotechnology company that aims to prevent diseases by restoring gut microbial ecology through microbiome-based therapies. The company is based in Thebarton, Australia. Biomebank's product is the world's first approved microbiome-based therapy for the treatment of recurrent and refractory clostridioides difficile infection. The company was founded by Rob Bryant and Sam Costello, with Sam Costello serving as the CEO since incorporation. | Health Technology |
